THOROLD, ON, March 2, 2016 /CNW/ – Norgen Biotek Corp., an innovative Canadian biotechnology company focusing on advancing powerful tools for DNA, RNA and protein stabilization and purification, today announced the signing of a supplier agreement with Biodesix, Inc. to ...
Read More »World’s First Exosomal RNA-Based Liquid Biopsy is Launched
ExoDx Lung(ALK) is the World’s First Non-invasive Test Allowing Identification of Specific ALK Fusions Using Exosomal RNA-Based Liquid Biopsy ExoDx Lung(ALK) is the First in a Series of Exosomal RNA-based Liquid Biopsies across Multiple Bio-fluids and Solid Tumors Expected to ...
Read More »Detection of EML4-ALK mutation and specific associated RNA fusion transcripts in blood plasma of patients with non-small cell lung cancer (NSCLC)
In the study, the Exosome Diagnostics EML4-ALK assay detected all EML4-ALK fusion transcripts based on the presence of the ALK kinase domain; importantly for therapy selection, the assay was able to differentiate between the three major known fusion transcript variants, ...
Read More »